• P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

Article Detail

Home > Article Detail
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

Article Contents

    Purity assignment of 17α-hydroxyprogesterone by mass balance method to establish traceability in measurement

    Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2019, v.32 no.6, pp.225-232
    https://doi.org/10.5806/AST.2019.32.6.225
    Hwa Shim Lee (Center for Bioanalysis, Division of Chemical and Medical Metrology, Korea Research Institute of Standards and Science)
    Su Jin Park (Cultural Heritage Conservation Science Center, National Research Institute of Cultural Heritage)
    • Downloaded
    • Viewed

    Abstract

    Traceability establishment in chemical measurements is a like a linkage established through an unbroken chain from the measured results to the international system (SI) of units. The primary process for traceability establishment is the purity assignment of a target material to be measured. In this study, we studied the purity assignment of 17α-hydroxyprogesterone (17-OHP). The presence of 17-OHP is indicative of congenital adrenal hyperplasia (CAH) and it builds up due to the deficiency of 21-hydroxylase and 11β-hydroxylase enzyme in the human blood. The purity assignment of 17-OHP was performed by the mass balance method, in which the impurities are categorized into four classes: total related structural impurities, water, residual organic solvents, and nonvolatiles/inorganics. The total related structural impurities were characterized by HPLC-UV; water content was determined by Karl-Fisher coulometer; and the total residual solvents and nonvolatiles/inorganics were determined by TGA. The purity of 17-OHP from a commercial manufacturer was calculated as 993.30 mg/g, and the expanded uncertainty was 0.58 mg/g. The proposed method was validated by uncertainty evaluation and comparing with the actual value of purity.

    keywords
    17-OHP, purity, traceability, mass balance method, CAH


    Reference

    1

    1. K. J. Pijnenburg-Kleizen, M. Engels, C. F. Mooij, A. Griffin, N. Krone, P. N. Span, A. E. Herwaarden-van, F. C. Sweep, and H. L. Claahsen-van der Grinten, Endocrinology, 156(10), 3504-3510 (2015).

    2

    2. M. I. New and L. S. Levine, Clinical Biochemistry, 14(5), 258-272 (1981).

    3

    3. P. F. Collett-Solberg, Clin Pediatr., 40(1), 1-16 (2001).

    4

    4. A. T. Soliman, M. Omar, M. Al Ali, M. M. Rizk, I. Nasr, and M. AbolMagd, Journal of Tropical Pediatrics, 52(2), 147-148 (2006).

    5

    5. A. Rosler, A. Milewicz, S. Korth-Schlitz, D. Haack, K. Lichtwald, and P. Vecsei, The Journal of Steroid Biochemistry, 17(3), lxxviii (1982).

    6

    6. R. Fingerhut, Steroids, 74(8), 662-665 (2009).

    7

    7. N. Huong, N. Dat, N. Hoan, B. Thao, N. Khanh, C. Ngoc, V. Dung, International Journal of Pediatric Endocrinology, 2013(suppl1), 124 (2013).

    8

    8. T. A. S. S. Bachega, A. E. C. Billerbeck, J. A. M. Marcondes, G. Madureira, I. J. P. Arnhold, and B. B. Mendonca, Clin Endocrinology, 52(5), 601-607 (2000).

    9

    9. S. Cho, J. Ko, and K. Lee, Journal of the Korean Society of Inherited Metabolic Disease, 16(2), 70-78 (2016).

    10

    10. H. Chung, C. Shin, S. Yang, K. Yun, Y. Lee, S. Park, C. Choi, B. Kim, J. Choi, and J. Song, Korean Journal of Pediatrics, 51(6), 616-621 (2008).

    11

    11. B. L. Therrell, Endocrinol. Metab. Clin. North Am., 30(1), 15-30 (2001).

    12

    12. S. Zhang, S. R. Mada, M. Torch, D. Mattison, S. Caritis, R. Venkataramanan, and O. Network, Mass Spectrometry and Allied Topics, 1638 (2008).

    13

    13. D. Foley, G. Hammond, B. Dugas, and L. Calton, Clinica Chimica Acta, 493(suppl1), S325 (2019).

    14

    14. S. A. Wudy, M. Hartmann, and M. Svoboda, Horm. Res, 53(2), 68-71 (2000).

    15

    15. ISO/IEC 17025, 3rd edition, 2017-11.

    16

    16. ISO 17511 (2003).

    17

    17. European Council Directive 98/79/EC (1998).

    18

    18. S. Westwood, T. Choteau, A. Daireaux, R. D. Josephs, and R. Wielgosz, Anal. Chem., 85, 3118 (2013).

    19

    19. H. Lee, S. Park, E. Ahn, S. Kim, G. Lee, and M. Kim, Bull. Korean Chem. Soc., 37(3), 418-421 (2016).

    20

    20. S. Westwood, R. Josephs, T. Choteau, A. Daireaux, R. Wielgosz, S. Davies, M. Moad, B. M. N. Chan, A. oz et al, Metrologia, 51, 08010 (2014).

    21

    21. R. D. Josephs, A. Daireaux, S. Westwood, and R. I. Wielgosz, Journal of Chromatography A, 1217(27), 4535-4543 (2010).

    22

    22. S. Westwood, R. Josephs, T. Choteau, A. Daireaux, C. Mesquida, and R. Wielgosz et al, Metrologia, 49, 08014(2012).

    23

    23. S. Westwood, R. Josephs, A. Daireaux, R. Wielgosz, and S. Davies et al, Metrologia, 49, 08009 (2012).

    24

    24. R. D. Josephs, A. Daireaux, T. Choteau, S. Westwood, and R. I. Wielgosz, Analytical and Bioanalytical Chemistry, 407(11), 3147-3157 (2015).

    25

    25. JCGM, 100 (2008).

    26

    26. JCGM. 200 (2012).

    상단으로 이동

    Analytical Science and Technology